Project description DEENESFRITPL The GyroGlove: a novel device for hand tremors sufferers Hand tremors in Essential Tremor (ET) and Parkinson’s Disease (PD) are debilitating and widespread. Current tremor symptoms management is poor for both ET and PD sufferers. Coordinated by GyroGear Ltd, the EU-funded GyroGlove project proposes a novel solution, the GyroGlove, to stabilise and better manage hand tremors. The GyroGlove is a wearable smart glove that exploits miniaturised gyroscopes to counteract the force generated by the tremors. It aims to restore independence and enhance the quality of life of hand tremors sufferers. Through this project, GyroGear will finalise the engineering design specification for the GyroGlove, build functional and pre-production prototypes for initial testing and user evaluations, manufacture the optimised GyroGlove, and conduct clinical trials to obtain regulatory approval for subsequent commercialisation (expected in early 2022). Show the project objective Hide the project objective Objective GyroGlove is a wearable active device based on miniaturised gyroscopes, designed to suppress the hand tremor commonlyseen in people suffering from Parkinson’s Disease (PD) or Essential Tremor (ET). With the help of Innovate UK Proof ofConcept (PoC) grant we have taken the idea from very early lab simulators through to functional prototypes. These weretested on PD and ET patients in lab conditions. We were able to demonstrate a 50% reduction in tremor in half of the testsand as much as 95% in one case. GyroGlove has commenced pre-production development (as of Nov 2017). The teamhas achieved TRL 6 as of this application and demonstrated proof-of-concept with group patient tests (30 users). TheGyroGlove form-factor comprises a lightweight/comfortable mount for an enclosed gyroscope which spins at approximately20,000 RPM. By stabilising the hand directly, the GyroGlove is targeted at multi-function use (eating, drinking, writing, selfcareetc.) to return independence and freedom to users. Given development and user testing success thus far, the phase 2project will enable us to: finalise engineering design specification; build functional and pre-production prototypes; transfer tomanufacture; conduct clinical trials and gain regulatory approval; develop supply chain agreements and commercialcontracts ready for full commercialisation and multiple-market entry in Q4 2022 . Fields of science natural sciencescomputer and information sciencesartificial intelligencemedical and health sciencesmedical biotechnologyengineering and technologymechanical engineeringvehicle engineeringaerospace engineeringsatellite technologymedical and health sciencesbasic medicineneurologyparkinson Keywords Parkinson's Disease Essential Tremor Wearable devices Disease management Hand tremor Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Topic(s) EIC-SMEInst-2018-2020 - SME instrument Call for proposal H2020-EIC-SMEInst-2018-2020 See other projects for this call Sub call H2020-SMEInst-2018-2020-2 Funding Scheme SME-2 - SME instrument phase 2 Coordinator GYROGEAR LIMITED Net EU contribution € 1 857 238,25 Address 90A HIGH STREET HP4 2BL Berkhamsted United Kingdom See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region East of England Bedfordshire and Hertfordshire Hertfordshire Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Total cost € 2 653 197,50
